Recombinant Human MDH2 Protein，His

MDH2, or malate dehydrogenase 2, is an important enzyme involved in the tricarboxylic acid (TCA) cycle, catalyzing the interconversion of malate and oxaloacetate while playing a crucial role in cellular metabolism and energy production. As a member of the malate dehydrogenase family, MDH2 primarily functions in the mitochondria, impacting the metabolic pathways that are essential for cellular respiration and the production of ATP. Recent studies have highlighted the significance of MDH2 in various physiological processes and its potential implications in metabolic disorders, cancer, and neurodegenerative diseases. The recombinant expression of MDH2 facilitates detailed biochemical characterization, structure-function studies, and exploration of its interactions with other metabolic enzymes and substrates. By producing MDH2 as a recombinant protein, researchers can obtain large quantities of pure enzyme necessary for kinetic analysis and inhibitor screening, thus understanding its role in health and disease. Additionally, given its involvement in critical metabolic pathways, MDH2 presents a promising target for therapeutic interventions aimed at metabolic regulation. Understanding the structure and function of MDH2 through recombinant protein studies could pave the way for novel strategies in treating metabolic diseases and improving energy homeostasis in cells, making it a significant subject of ongoing biochemical research. As such, MDH2 not only provides insights into fundamental metabolic processes but also represents a key player in the development of innovative treatments for a variety of metabolic disorders.